Making a Hematopoietic Stem Cell

Trends in Cell Biology

Volumn 26, Issue 3, 2016, Pages 202-214

  Daniel, Michael G ^a   Pereira, Carlos Filipe ^b   Lemischka, Ihor R ^a   Moore, Kateri A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Hematopoiesis; Hematopoietic stem cell; Reprogramming; Transcription factors

Indexed keywords

FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; TRANSCRIPTION FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PLASTICITY; CELL REPROGRAMMING TECHNIQUE; COLONY FORMING UNIT; DENDRITIC CELL; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENGRAFTMENT; ERYTHROCYTE; EX VIVO STUDY; FIBROBLAST; HEMANGIOBLAST; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; STEM CELL EXPANSION; T LYMPHOCYTE; THROMBOCYTE; ANIMAL; CELL CULTURE; CELL CULTURE TECHNIQUE; INDUCED PLURIPOTENT STEM CELL; NUCLEAR REPROGRAMMING; PHYSIOLOGY;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CELLULAR REPROGRAMMING; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84958672483     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2015.10.002     Document Type: Review

References (89)

1. Takizawa H., et al. Ex vivo expansion of hematopoietic stem cells: mission accomplished?. Swiss Med. Wkly. 2011, 141:w13316.
2. Siena S., et al. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J. Clin. Oncol. 2000, 18:1360-1377.
3. Petersdorf E.W. The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood 2013, 122:1863-1872.
4. Boitano A.E., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329:1345-1348.
5. Fares I., et al. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 2014, 345:1509-1512.
6. Chaurasia P., et al. Epigenetic reprogramming induces the expansion of cord blood stem cells. J. Clin. Invest. 2014, 124:2378-2395.
7. Liu M.L., et al. Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat. Commun. 2013, 4:2183.
8. Federation A.J., et al. The use of small molecules in somatic-cell reprogramming. Trends Cell Biol. 2014, 24:179-187.
9. Zhang Y., et al. Small molecules, big roles - the chemical manipulation of stem cell fate and somatic cell reprogramming. J. Cell Sci. 2012, 125:5609-5620.
10. Xu Y., et al. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008, 453:338-344.
11. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
12. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
13. Lee T.I., Young R.A. Transcriptional regulation and its misregulation in disease. Cell 2013, 152:1237-1251.
14. Pereira C.F., et al. Reprogramming cell fates: insights from combinatorial approaches. Ann. N.Y. Acad. Sci 2012, 1266:7-17.
15. Orkin S.H. Transcription factors and hematopoietic development. J. Biol. Chem. 1995, 270:4955-4958.
16. Pulecio J., et al. Conversion of human fibroblasts into monocyte-like progenitor cells. Stem Cells 2014, 32:2923-2938.
17. Kurian L., et al. Conversion of human fibroblasts to angioblast-like progenitor cells. Nat. Methods 2013, 10:77-83.
18. Vierbuchen T., et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
19. Sekiya S., Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475:390-393.
20. Qian L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
21. Choi J., et al. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:7988-7992.
22. Davis R.L., et al. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
23. Son E.Y., et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 2011, 9:205-218.
24. Ieda M., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
25. Buganim Y., et al. Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors. Cell Stem Cell 2012, 11:373-386.
26. Feng R., et al. PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6057-6062.
27. Han D.W., et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 2012, 10:465-472.
28. Huang P., et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475:386-389.
29. Najm F.J., et al. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat. Biotechnol. 2013, 31:426-433.
30. Pereira C.F., et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 2013, 13:205-218.
31. Zhou Q., Melton D.A. Extreme makeover: converting one cell into another. Cell Stem Cell 2008, 3:382-388.
32. Robinton D.A., Daley G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481:295-305.
33. Papapetrou E.P., Sadelain M. Reconstructing blood from induced pluripotent stem cells. F1000 Med. Rep. 2010, 2:44.
34. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
35. Kim P.G., Daley G.Q. Application of induced pluripotent stem cells to hematologic disease. Cytotherapy 2009, 11:980-989.
36. Lim W.F., et al. Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells. Stem Cell Res. Ther. 2013, 4:71.
37. Keller G., et al. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 1993, 13:473-486.
38. Hole N., et al. A limited temporal window for the derivation of multilineage repopulating hematopoietic progenitors during embryonal stem cell differentiation in vitro. Blood 1996, 88:1266-1276.
39. Choi K.D., et al. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep. 2012, 2:553-567.
40. Zovein A.C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636.
41. Bertrand J.Y., et al. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 2010, 464:108-111.
42. Gordon-Keylock S., Medvinsky A. Endothelio-hematopoietic relationship: getting closer to the beginnings. BMC Biol. 2011, 9:88.
43. Chen M.J., et al. Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell 2011, 9:541-552.
44. Antas V.I., et al. Hemogenic endothelium: a vessel for blood production. Int. J. Biochem. Cell Biol. 2013, 45:692-695.
45. Chen M.J., et al. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457:887-891.
46. Sturgeon C.M., et al. Defining the path to hematopoietic stem cells. Nat. Biotechnol. 2013, 31:416-418.
47. Boiers C., et al. Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells. Cell Stem Cell 2013, 13:535-548.
48. Lancrin C., et al. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457:892-895.
49. Amabile G., et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 2013, 121:1255-1264.
50. Takaki S., et al. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J. Exp. Med. 2002, 195:151-160.
51. Suzuki N., et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol. Ther. 2013, 21:1424-1431.
52. Forrester L.M., Jackson M. Mechanism of action of HOXB4 on the hematopoietic differentiation of embryonic stem cells. Stem Cells 2012, 30:379-385.
53. McKinney-Freeman S.L., et al. Isolation of hematopoietic stem cells from mouse embryonic stem cells. Curr. Protoc. Stem Cell Biol. 2008, (Suppl 4). 1F.3.1-1F.3.10.
54. Kyba M., et al. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002, 109:29-37.
55. Tashiro K., et al. Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction. Stem Cell Res. 2012, 8:300-311.
56. Wang Y., et al. Embryonic stem cell-derived hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19081-19086.
57. Chadwick K., et al. Cytokines and BMP-promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
58. Bowles K.M., et al. HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells 2006, 24:1359-1369.
59. Wang L., et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med. 2005, 201:1603-1614.
60. Doulatov S., et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 2013, 13:459-470.
61. Elcheva I., et al. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nat. Commun. 2014, 5:4372.
62. Clarke R.L., et al. The expression of Sox17 identifies and regulates haemogenic endothelium. Nat. Cell Biol. 2013, 15:502-510.
63. Ditadi A., et al. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat. Cell Biol. 2015, 17:580-591.
64. Corada M., et al. Sox17 is indispensable for acquisition and maintenance of arterial identity. Nat. Commun. 2013, 4:2609.
65. Nakajima-Takagi Y., et al. Role of SOX17 in hematopoietic development from human embryonic stem cells. Blood 2013, 121:447-458.
66. Ran D., et al. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood 2013, 121:2882-2890.
67. Real P.J., et al. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol. Ther. 2012, 20:1443-1453.
68. Bar-Nur O., et al. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nat. Biotechnol. 2015, 33:761-768.
69. Maza I., et al. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Nat. Biotechnol. 2015, 33:769-774.
70. Szabo E., et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
71. Mitchell R., et al. Molecular evidence for OCT4-induced plasticity in adult human fibroblasts required for direct cell fate conversion to lineage specific progenitors. Stem Cells 2014, 32:2178-2187.
72. Qiu J., et al. Divisional history and hematopoietic stem cell function during homeostasis. Stem Cell Rep. 2014, 2:473-490.
73. Pereira C.F., et al. There will be blood" from fibroblasts. Cell Cycle 2014, 13:335-336.
74. Batta K., et al. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep. 2014, 9:1871-1884.
75. Vereide D.T., et al. An expandable, inducible hemangioblast state regulated by fibroblast growth factor. Stem Cell Rep. 2014, 3:1043-1057.
76. Riddell J., et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014, 157:549-564.
77. Sandler V.M., et al. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 2014, 511:312-318.
78. Butler J.M., et al. Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. Blood 2012, 120:1344-1347.
79. Gori J.L., et al. Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells. J. Clin. Invest. 2015, 125:1243-1254.
80. Vierbuchen T., Wernig M. Direct lineage conversions: unnatural but useful?. Nat. Biotechnol. 2011, 29:892-907.
81. Cherry A.B., Daley G.Q. Reprogrammed cells for disease modeling and regenerative medicine. Annu. Rev. Med. 2013, 64:277-290.
82. Sadelain M. Insertional oncogenesis in gene therapy: how much of a risk?. Gene Ther. 2004, 11:569-573.
83. Persons D.A. Lentiviral vector gene therapy: effective and safe?. Mol. Ther. 2010, 18:861-862.
84. Mandal P.K., Rossi D.J. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat. Protoc. 2013, 8:568-582.
85. Warren L., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
86. Yoshioka N., et al. Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 2013, 13:246-254.
87. Vaskova E.A., et al. Epigenetic memory" phenomenon in induced pluripotent stem cells. Acta Nat. 2013, 5:15-21.
88. Kim K., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
89. Papp B., Plath K. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res. 2011, 21:486-501.